About Centro Gamma Knife
Gamma Knife – a unique approach
The Technology
The Leksell Gamma Knife Perfexion® unit installed at Hospital CUF Tejo incorporates the latest technological advances in high-precision radiation for lesions in the brain, head and upper cervical spine.
Gamma Knife® surgery opens up new possibilities in the treatment of benign and malignant brain tumours, vascular lesions, metastases and functional disorders. Treatment involves no incision in the skull and has very few side effects. It is carried out in a single session, under local anaesthesia only, with discharge home within 24 hours.


Gamma Knife radiosurgery offers several advantages.
Compared with conventional surgery, the risk of complications is lower and side effects for the patient are much milder.
Treatment is carried out in a single session and recovery time is extremely short.
To date, more than 500,000 patients worldwide have undergone Gamma Knife surgery, and around 50,000 benefit from this treatment every year. Where available and appropriate, it is the method preferred by patients.
The Equipment
O Gamma Knife Perfexion® is unique equipment in Portugal that directs 192 gamma-ray beams at a predefined area within the skull with sub-millimetre precision.
Using a sophisticated three-dimensional system to locate and position the patient’s head, the Gamma Knife achieves an accuracy of less than 0.5 mm. The radiation reaches the diseased cells with a high concentration of energy, sparing the surrounding healthy tissue.
This technology makes it possible to treat a range of benign and malignant brain tumours, arteriovenous malformations and neuralgias that, in many cases, cannot be reached with conventional surgery.
What Is Gamma Knife Radiosurgery
Single-dose stereotactic radiosurgery is a neurosurgical treatment first described by Professor Lars Leksell in the 1960s.
He defined it as the delivery of a single dose of radiation to a small intracranial volume without opening the skull. In this way, brain lesions can be destroyed non-invasively without significant damage to the normal tissue around them. It is used for lesions in the brain or other structures inside the skull, and is particularly useful when the lesion lies close to critical structures.
The aim is to stop tumour growth, induce changes in abnormal brain blood vessels or produce functional changes, for example in hormone-secreting pituitary tumours or in severe facial pain (trigeminal neuralgia).